This Study DESTROYS What We Thought About Cancer

A 2024 paper in the Journal of Cancer Therapy reported a 35-fold improvement in response rates and 88% measurable symptom improvement in late-stage cancer patients treated under a precision oncology protocol, compared to the standard-of-care benchmarks every major cancer center uses. The data was validated by a third-party actuarial firm. After 25 years of treating cancer patients, I did not expect to see numbers like these in print. In this video, I walk you through exactly what the study measured, why the actuarial validation matters more than the headline figures, and what it means if you or someone you love is currently sitting in front of an oncologist. We cover what "standard of care" actually is (and why it is the statistical average, not the ceiling of what is possible), how the study was designed, what a 35x response rate and 88% symptom improvement look like in real patient terms, and the mechanism behind the result: the shift from population-averaged protocols to patient-specific precision oncology based on tumor sequencing and targeted treatment. Most importantly, I lay out the practical next steps. What to ask your oncologist, when to get a second opinion, how to identify a clinic that actually practices precision oncology, and the honest reality about insurance coverage for this kind of care. This is not hype. This is one paper, one cohort, and the strongest real-world evidence we have that the biological ceiling many late-stage patients are told to accept is not actually a ceiling. 📍 Envita Medical Centers – Scottsdale, AZ 🌐 Learn more: https://www.envita.com/?utm_source=Dr... 📞 Speak with a care coordinator: 866-830-4576 “Prevention isn’t just about what you avoid — it’s about how you support your body.” #OutsmartCancer #CancerPrevention #GutHealth #PrecisionOncology #DrDinoPrato 🧬 About Dr. Dino Prato and Envita Medical Centers My life's work at Envita Medical Centers has been a mission to help patients find hope when they've run out of options. As a pioneer in precision personalized medicine, I founded Envita Medical Centers to offer next-level care. We use state-of-the-art testing and treatments that are not only data-driven but also precisely targeted to each individual. By the grace of God, we've been able to help many families. Our approach isn't about treating a disease; it's about treating a unique person and providing a custom blueprint for healing. We believe every life is precious and unrepeatable, and we approach each patient with the love and dignity they deserve. The message we give them is one of life and hope. 📍 Envita Medical Centers – At Envita Medical Centers in Scottsdale, AZ, we believe in a radical, loving approach to patient care. Our unique campus is home to a dedicated team of over 400 professionals, including doctors (MD, DO, NMD), pharmacists, nurses, and researchers, all working together in a seamless ecosystem. To learn more, visit: https://www.envita.com/?utm_source=Dr... Disclaimer This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied. ________________________________________ Outcomes Disclaimer The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary. You can read the full peer-reviewed study at: https://www.scirp.org/journal/paperin...